Our DermatologistsNYU UPN Dermatologists
- Roy G. Geronemus, M.D.
- Robert T. Anolik, M.D.
- Yoon-Soo Cindy Bae, M.D.
- Jeremy A. Brauer, M.D.
- Roy Seidenberg, M.D.
- Leonard J. Bernstein, M.D.
- Wilfred Brown, M.D., F.A.C.S.
- Ronald Shelton, M.D.
- Jessica J. Krant, M.D.
- Paul M. Friedman, M.D.
- Dana Stern, M.D.
- Elliot T. Weiss, M.D.
- Michelle F. Henry, M.D.
Hemangioma Treatment and RemovalRoy G. Geronemus, M.D.; Leonard J. Bernstein, M.D.; Elliott T. Weiss, M.D.; Robert T. Anolik, M.D.; Jeremy A. Brauer, M.D.; Yoon-Soo Cindy Bae, M.D.; Ron M. Shelton, M.D.; and Michelle F. Henry, M.D., are world leaders in the treatment of birthmarks including Port Wine Stains and hemangiomas. Our physicians have over thirty three (33) years experience in the treatment of hemangiomas and related vascular birthmarks. Our center specializes in the outpatient management of patients with this condition and services can also be provided at the New York Eye & Ear Infirmary for those patients requiring general anesthesia.
Our highly experienced and dedicated team of physicians and nurses cater to the needs of hemangioma patients. Most insurance plans are accepted for treatment and our insurance staff works diligently to help our patients receive insurance coverage. We offer a variety of different lasers for the treatment of hemangiomas including the V-Beam laser, Gentlelase laser, Excel V laser, alexandrite laser, nd:YAG laser, and Fraxel lasers.
Treatments in the office are performed with either topical anesthesia (EMLA or Elamax), local anesthesia or none. We begin treatment in early infancy to facilitate the optimum response and ultimate outcome. Typically, multiple treatments are required and a complete cure is not always possible. Treatment intervals are usually at two weeks intervals for infants but may vary based upon the variety of factors including the location of the hemangioma and the age of the patient. Our physicians have helped develop many, if not most, of the laser technology available today for the treatment of hemangiomas. We continually offer the most current treatment for our patients in this rapidly evolving field and in selected cases utilize laser in combination with oral propranolol and/or topical timolol. Our publication of the combined use of propranolol and pulsed dye laser treatment together showed faster resolution of the hemangiomas with a shorter course of propranolol and less rebound growth after discontinuation of the oral medicine. This combined approach has become our standard treatment for many of the hemangiomas that have a deeper or thicker component.
Mature hemangiomas that have not resolved spontaneously in older children, teenagers and adults are also excellent candidates for laser treatment.
View Before & After photos
In The News1st Sergeant Scott L. Cupples of the United States Air Force first contacted Dr. Linda Rozell-Shannon and the Vascular Birthmarks Foundation (VBF) to attend their annual conference being held in New York City on October 8, 2016.
Click to read press release
Roy G. Geronemus, M.D., and the Vascular Birthmarks Foundation iTeam travel to Parma, Italy 2016
The International Symposium On Hemangiomas and Vascular Malformations was held in Parma, Italy this year. Dr. Geronemus gave three lectures:
"Treatment of Cutaneous Vascular Anomalies with Laser Therapy"
"Laser Treatment Parameters for Maximum Results"
"Adjuvant Laser as with a Drug Therapy"
Roy G. Geronemus, M.D., and the Vascular Birthmark Foundation visit Isreal 2015
February 18-19, 2015 the VBF iTEAM, along with program founder and VBF President, Dr. Linda Rozell-Shannon, participated in a two day Vascular Anomalies Conference at the Sackler Medical School in Tel-Aviv University, Israel.
Click to read more
Dr. Roy G. Geronemus spoke at the 2014 ASDS Conference in San Diego, CA about how pediatric patients can benefit from laser treatments - Dermatology Times (2014)
The Vascular Birthmark Foundation presented Dr. Roy Geronemus the VBF Humanitarian Award for his work with the international VBF iTeam and his support of our annual conference.
Dr. Geronemus and the VBF ITeam have traveled to Russia and India, providing free treatment to hundreds of patients with vascular birthmarks. He also provided free laser treatment for patients attending the VBF annual conference. International Patients were also treated at the Laser & Skin Surgery Center of New York as part of the Vascular Birthmark Foundation Conference. Drs. Geronemus and Bernstein provided complimentary laser treatments to infants, children and adults with vascular birthmarks. Patients from England, Switzerland, Brazil, China, Argentina, Canada were amongst the patients seeking advice and treatments from our physicians.
New Publication from Our Physicians
The Physicians at the Laser & Skin Surgery Center of New York have published a new article in the prestigious Archives of Dermatology (08/2012).
"Ablative Fractional Resurfacing for Involuted Hemangioma Residuum"
Click here to read more
Dr. Roy G, Geronemus and team are currently in Delhi, India with the Vascular Birthmark Foundation
Dr. Roy Geronemus is currently in Delhi, India (Feb. 2014) to speak and voluntarily treat children with port wine stains and hemangiomas. He is accompanied by his assistants Dr. Yoon-Soo Cindy Bae, Wendy Olin, RN, and Katie Feehan, RN. The LSSCNY team will be collaborating with a group of physicians from the Vascular Birthmark Foundation.
There are over 170 children and adults scheduled for treatment by the VBF iTEAM (International missions team).
Dr. Roy G. Geronemus traveled to Moscow to treat children with port wine stains and hemangiomas
Dr. Roy G. Geronemus traveled to Moscow, Russia to participate in “The International Conference with the Practical Course: Vascular Skin Tumors and Malformations in Children: Diagnosis and Management” on June 6-7, 2012. In addition to his lecture entitled “Treatment of Infantile Lesions (Vascular/Non-Vascular),” Dr. Geronemus treated Russian children at a local hospital.
Click here to read more
Dr. Roy G. Geronemus co-hosting the annual Vascular Birthmarks Conference
Dr. Roy G. Geronemus will be co-hosting the Vascular Birthmarks Conference to be held in New York City on November 10, 2012. Patient consultations will take place at the Laser & Skin Surgery Center of New York.
Click here for more information
Dr. Roy G. Geronemus receives Physician of the Year award
Dr.Geronemus received the "Physician of the Year" award from the Hemangioma Vascular Birthmark Foundation this November. The award was presented to Dr. Geronemus by the foundation at their annual meeting in New York City on November 14, 2008.
Dr. Roy G. Geronemus & the Physicians at the Laser & Skin Surgery Center of New York host the annual vascular birthmark conference
The Vascular Birthmarks Foundation along with Dr. Roy Geronemus and The Laser & Skin Surgery Center of New York Present The 2010 Vascular Birthmarks Conference on October 9, 2010 at the NYU Medical Center and the Laser & Skin Surgery Center of New York.
Laser & Skin Surgery Center of New York receives Award for Best Clinical Science Paper
The physicians of the Laser & Skin Surgery Center of New York received the award for Best Overall Clinical Science Paper. The paper entitled “Efficacy Of Early Treatment Of Facial Port-Wine Stains In Newborns: A Review Of 49 Cases” has been selected by the American Society for Laser Medicine and Surgery as the Best Overall Clinical Science Paper submitted for the 27th Annual Conference.
The Laser & Skin Surgery Center of New York is pleased to announce that we have added two V-Beam Perfectas to our existing group of lasers.
These lasers provide another option for our physicians in the treatment of port wine stains, hemangiomas, and other vascular birthmarks. One of the advantages of these lasers are that they allow for the consistent delivery of high energy and utilize a larger spot size. In addition, the other characteristics of V-Beam technology remain including a variable pulsewidth and a variety of spot sizes and energy fluences. These devices are used with the dynamic cooling spray which allows for the safe delivery of higher energy fluences. Our physicians have worked with Candela laser in the development of this device.
The Laser & Skin Surgery Center of New York is pleased to introduce the Cynergy laser for the treatment of port wine stains
This laser utilizes a combination of two different wavelengths, commonly found in two separate and distinct lasers. Both the 595 nm and 1064 nm wavelengths are used simultaneously with sequential pulses when this laser is utilized. The advantage of this laser is that it allows for deeper penetration of the laser beam and minimizes the post-operative bruising seen in laser treatments relative to standard treatments with the pulsed dye lasers that are available today. This procedure requires topical and oral anesthesia and generally leaves a bruising effect that could be as short as two days with significant improvement noted in most patients. At this point in time, the Cynergy laser treatment is limited to adults only.
Hemangioma ReferencesTerushkin V1, Brauer J, Bernstein L, Geronemus R. Effect of General Anesthesia on Neurodevelopmental Abnormalities in Children Undergoing Treatment of Vascular Anomalies With Laser Surgery: A Retrospective Review.Dermatol Surg. 2016 Dec 26. doi: 10.1097
Brauer JA, Geronemus RG. Laser treatment in the management of infantile hemangiomas and capillary vascular malformations. Tech Vasc Interv Radiol. 2013 Mar: 16(1):51-4.
Reddy KK, Blei F, Brauer JA, Waner M, Anolik R, Bernstein L, Brightman L, Hale E, Karen J, Weiss E, Geronemus RG “Retrospective study of the treatment of infantile hemangiomas using a combination of propranolol and pulsed dye laser” Dermatol Surg. 2013 Jun;39(6):923-33.
Geronemus RG. Commentary of “Beneficial effects of early pulsed dye laser therapy in patients with infantile hemangiomas.” Dermatol Surg. 2012 Oct; 38(10):1739-40.
Brightman LA, Brauer JA, Terushkin V, Hunzeker C, Reddy KK, Weiss ET, Karen JK, Hale EK, Anolik R, Bernstein L, Geronemus RG. “Ablative Fractional Resurfacing for Involuted Hemangioma Residuum.” Arch Dermatol. 2012 Nov; 148(11): 1294-8.
Reddy KK, Blei F, Brauer JA, Waner M, Berstein L, Brightman LA, Hale EK, Karen JK, Weiss ET,Geronemus RG. "Infantile hemangiomas treated with a combination of propranolol and pulsed dye laser."Lasers Surg Med. 2012; 44(S24):3-4.
Brauer JA, Anolik R, Tzu J, Meehan S, Lieber CD, Geronemus RG. “Glomuvenous Malformations (familial generalized multiple glomangiomas)” Dermatol Online J. 2011 Oct; 17(10):9. Review.
Geronemus RG, Hunzeker CM. "Letter regarding early laser treatment of periorbital infantile hemangiomas may work, but is it really the best treatment option?" Dermatol Surg. 2010; 36(9):1495-97.
Geronemus RG, Hunzeker CM. “Early laser treatment of periorbital infantile hemangiomas may work, but is it really the best treatment option?” Dermatol Surg. 2010 Sep; 36(9):1495-7.
Hunzeker C, Geronemus R. "Treatment of Superficial Infantile Hemangiomas of the Eyelid USing the 595-nm Pulsed Dye Laser." Dermatol Surg. 2010 May; 36(5):590-597.
Rizzo C, Brightman L, Chapas AM, Hale EK, Cantatore-Francis JL, Geronemus RG. “Outcomes of Childhood Hemangiomas Treated with the Pulsed-Dye Laser with Dynamic Cooling: A Retrospective Chart Analysis.” Dermatol Surg. 2009 Dec; 35(12):1947-54.
Chapas AM, Geronemus RG. "Our approach to pediatric dermatologic laser surgery." Lasers Surg Med. 2005 Oct; 37(4):255-63.
Dinehart SM, Kincannon J, Geronemus R. "Hemangiomas: evaluation and treatment."Dermatol Surg. 2001 May; 27(5):475-85.
Blei F, Orlow SJ, Geronemus R. "Multimodal management of diffuse neonatal hemangiomatosis." J Am Acad Dermatol. 1997 Dec; 37(6):1019-21.
Frieden I, Eichenfield L, Esterly N, Geronemus R, Mallory S. "Guidelines of care for hemangiomas of infancy." J Am Acad Dermatol. 1997 Oct; 37(4):631-7.
Geronemus RG, Kauvar AN. "The pulsed-dye laser for infantile hemangiomas." Plast Reconstr Surg. 1996 May; 97(6):1302-3.
Levine VJ, Geronemus RG. "Adverse effects associated with the 577 - and 585 - nanometer pulsed dye laser in the treatment of cutaneous vascular lesions: a study of 500 patients." J Am Acad Dermatol. 1995 Apr; 32(4):613-7.
Blei F, Orlow SJ, Geronemus RG. "Interferon alfa-2a therapy for extensive perianal and lower extremity hemangioma." J Am Acad Dermatol. 1993 Jul; 29(1):98-9.
Geronemus RG. "Pulsed dye laser treatment of vascular lesions in children." J Dermatol Surg Oncol. 1993 Apr; 19(4):303-10.
Blei F, Orlow SJ, Geronemus RG. "Supraumbilical midabdominal raphe, sternal atresia, and hemangioma in an infant: response of hemangioma to laser and interferon alfa-2a." Pediatr Dermatol. 1993 Mar; 10(1):71-6.
Ashinoff R, Geronemus RG. "Failure of the flashlamp-pumped pulsed dye laser to prevent progression to deep hemangioma." Pediatr Dermatol. 1993 Mar; 10(1):77-80.
Ashinoff R, Geronemus RG. "Capillary hemangiomas and treatment with the flashlamp-pumped pulsed dye laser." Arch Dermatol. 1991 Feb; 127(2):202-5.
Ashinoff R, Geronemus RG. "Porokeratosis of Mibelli with underlying hemangioma treated by the flashlamp-pumped pulsed dye laser." Cutis. 1990 Nov; 46(5):410-2.